한스바이오메드

042520KOSDAQ의료용품 및 기타 의약 관련제품 제조업

44.0 / 100

Reference Date: 2026-06-10

Financial Score9.5 / 40

News Sentiment15.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Slightly up 3.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HansBioMed, established in 1999, develops, manufactures, and sells skin and bone tissue implants and medical devices. Its key products, Bella Cell HD and SureFuse, account for approximately 61% of sales, with global expansion through overseas subsidiaries in the U.S., Thailand, and the U.K. The company continues to invest in R&D for regenerative medicine and new medical technologies.

Number of Employees

289people

Average Salary

41.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.194.0Point

PBR

10.14Industry Average 1.300.0Point

7.8x industry avg (risky)

ROE

-63.51Industry Average -4.893.5Point

13.0x industry avg (excellent)

Debt Ratio

33.90Industry Average 6.860.0Point

4.9x industry avg (risky)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼2061.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -42.1% (declining, 3yr)

Detailed News Sentiment

7 totalPositive 3Neutral 4Negative 0Average Sentiment Score 62.1

Neutral
춘천 기업혁신파크, 서울 바이오기업 대상 'B-city' 사업 설명
바이오 관련 혁신파크 사업 설명이 춘천 기업혁신파크와 관련 있으나, 직접적인 영향은 제한적임.
Neutral
'바이오투자 한파' 비상장 기업 생존 해법은?
포럼 내용은 바이오 투자 환경 개선에 초점을 맞추고 있으나, 한스바이오메드의 직접적인 영향은 제한적이다.
Positive
한스바이오메드, 벨라젤 장기 안전성 관리 후향적 연구 추진…모니터...
한스바이오메드가 벨라젤 유방보형물 환자 장기 안전성 모니터링 연구를 통해 안전 관리 강화를 추진함으로써 신뢰도가 상승하고 있다.

Detailed Momentum

52-week position3.0Point

52w lower range (35%)

Current 24,100Won52-week high 55,70052-week low 7,030

1-month return4.0Point

1m +3.66% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-06-09
Neutral주식등의대량보유상황보고서(약식)2026-06-05
Neutral반기보고서 (2026.03)2026-05-14